miR155 Deficiency Reduces Myofibroblast Density but Fails to Improve Cardiac Function after Myocardial Infarction in...

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Genetics

Background:

• Myocardial infarction (MI) is a primary cause of heart failure and adverse cardiac remodeling.
• MicroRNA 155 (miR155) is upregulated post-MI and influences cardiac inflammation, fibrosis, and hypertrophy.
• Dyslipidemia exacerbates cardiac remodeling following MI.

Purpose of the Study:

• To investigate the role of miR155 in cardiac remodeling and dysfunction in a dyslipidemic mouse model of myocardial infarction.
• To determine if miR155 knockout impacts cardiac function and histological changes post-MI in apolipoprotein E-deficient (ApoE-/-) mice.

Main Methods:

• Myocardial infarction was induced in dyslipidemic ApoE-/- mice with and without miR155 knockout (ApoE-/-/miR155-/-).
• Echocardiography assessed left ventricular (LV) dimensions and function 4 weeks post-MI.
• Histological analysis evaluated infarction size, neoangiogenesis, myofibroblast density, and collagen deposition.

Main Results:

• No significant differences in LV ejection fraction, LV mass, or LV volumes were observed between ApoE-/- and ApoE-/-/miR155-/- mice.
• Infarction size and neoangiogenesis in the myocardial scar were comparable between groups.
• Myofibroblast density was significantly decreased in ApoE-/-/miR155-/- mice, while total collagen deposition remained unchanged.

Conclusions:

• Genetic deletion of miR155 in a dyslipidemic MI model does not ameliorate overall cardiac dysfunction or reduce infarct size.
• miR155 deficiency leads to reduced myofibroblast density within the post-ischemic cardiac scar.
• These findings suggest a specific role for miR155 in regulating scar cellularity, independent of overall cardiac remodeling and function post-MI in this model.